Sanofi-Aventis (France) Sets Up $200M Biotech Plant, Seeks Partnerships

May 6, 2009 |

1 min read

VITRY-SUR-SEINE, France, May 5 (Reuters) - Sanofi-Aventis (SASY.PA) announced a 200 million euro plan to convert a French factory to biotechnology, highlighting efforts by the world's fourth largest drugmaker to penetrate the growing sector.

Alliances Real estate Europe

Sanofi (France)

MORE ON THIS TOPIC

Illustration of cardboard box filled with office supplies, a computer keyboard, lamp, and a potted plant

Layoff Tracker

After $9.5B Blueprint Buyout, Sanofi Trims Preclinical Pipeline, Fires ‘Some’ Staff

November 14, 2025

·

84 min read

·

BioSpace Editorial Staff

Contemporary art collage of woman sitting in the lotus position, cloud, pillows against the background of the night sky. Concept of healthy lifestyle and sport. Good and relaxing sleep. Copy space.

Mergers & acquisitions

Another Bidding War Breaks as Lundbeck Bids for Sleep Biotech Avadel

November 14, 2025

·

1 min read

·

Annalee Armstrong

Investment mistakes, taxes, expenses, and unknown costs drain money, concept of Businessman carries a money bag with a big hole, banknotes falling out

Mergers & acquisitions

Merck Again Brings Out Big Bucks, Buys Cidara in $9.2B Antiviral Push

November 14, 2025

·

2 min read

·

Tristan Manalac

Different business strategies. Various solutions. Splitting opinions. Choosing way. Movement options. Separation of directions. Dilemma concept. Two diverging paths of arrows. 3d render

Vaccines

Pfizer Reportedly Planning To Divest BioNTech Stake

November 14, 2025

·

2 min read

·

Tristan Manalac